Minimally invasive mitral valve repair and ablation of atrial fibrillation, combined with FVIII level-controlled replacement therapy, can be safely performed in patients with severe hemophilia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422630 | PMC |
http://dx.doi.org/10.1002/ccr3.4174 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!